Alpha-2 adrenergic receptor function in post-stroke depression

Psychological Medicine

Volumn 20, Issue 2, 1990, Pages 305-309

  Barry, Siobhan ^a   Dinan, Timothy G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; DESIPRAMINE; GROWTH HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; STROKE;

AGED; CEREBRAL INFARCTION; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DEPRESSIVE DISORDER; DESIPRAMINE; DOMINANCE, CEREBRAL; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE; HUMAN; MALE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ADRENERGIC; SUPPORT, NON-U.S. GOV'T;

EID: 0025297311     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S003329170001761X     Document Type: Article

References (34)

1. Barry, S. & Dinan, T. G. (1990). Neuroendocrine challenge tests in depression: a study of growth hormone, TSH and Cortisol release. Journal of Affective Disorders (In the press.)
2. Bobarth, K. & Bobarth, B. (1978). Short assessment and treatment planning for adult hemiplegia. In Adult hemiplegia: Evaluation and Treatment (ed. B. Bobarth), pp. 28–57. Heinemann: London.
3. Charatan, F. B. & Fisk, A. (1978). The mental and emotional results of strokes. New York State Journal of Medicine 78, 1403–1405.
4. Charney, D. S., Heninger, G. R., Sternberg, D. E., Redmond, D. E., Leckman, J. F., Maas, J. W. & Roth, R. H. (1982). Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects. Archives of General Psychiatry 39, 290–294.
5. Checkley, S. A. (1985). Biological markers in depression. In Recent Advances in Clinical Psychiatry, Number 5 (ed. K. Granville-Grossman), pp. 201–224. Churchill-Livingstone: Edinburgh.
6. Checkley, S. A., Slade, A. P. & Shur, E. (1981). Growth hormone and other responses to clonidine in patients with endogenous depression. British Journal of Psychiatry 138, 51–55.
7. Checkley, S. A., Corn, T. H., Glass, I. B., Burton, S. W. & Burke, C. A. (1986). The responsiveness of central alpha-2 adrenoceptors in depression. In The Biology of Depression (ed. J. F. W. Deakin), pp. 100–120. Gaskell: London.
8. Corn, T. H., Hale, A. S., Thompson, C., Bridges, P. K. & Checkley, S. A. (1984). A comparison of the GH responses to clonidine and apomorphine in the same depressed patients. British Journal of Psychiatry 144, 636–639.
9. Dinan, T. G. & Barry, S. (1990). Growth hormone responses to desipramine in endogenous and non-endogenous depression. British Journal of Psychiatry. (In the press.)
10. Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975). A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189–198.
11. Folstein, M. F., Maiberger, R. & McHugh, P. (1977). Mood disorder as a specific complication of stroke. Journal of Neurology, Neurosurgery and Psychiatry 40, 1018–1020.
12. Glass, I. B., Checkley, S. A., Shur, E. & Dowling, S. (1982). The effect of desipramine upon central adrenergic function in depressed patients. British Journal of Psychiatry 141, 372–376.
13. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 23, 56–62.
14. Katona, C. L. E., Theodoru, A. E., Davies, S. L., Yamagushi, Y., Tunnicliffe, C. A., Hale, A. S., Horton, R. W., Kelly, J. S. & Paykel, E. S. (1986). Platelet binding and neuroendocrine responses in depression. In The Biology of Depression (ed. J. F. W. Deakin), pp. 121–136. Gaskell: London.
15. Laakman, G. (1980). Effects of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients. Nervenarzt 51, 725–732.
16. Laakman, G., Dieterle, D., Weiss, L. & Schmauss, M. (1981). Therapeutic and neuroendocrine studies using yohimbine and antidepressants in depressed patients and healthy subjects. In New Vistas in Depression (ed. S. Z. Langer, R. Takahastin, T. Segawa and M. Briley), pp. 295–301. Pergamon: New York.
17. Laakman, G., Zygan, K., Schoen, H. W., Weiss, A., Wittman, M., Meissner, R. & Blaschke, D. (1986). Effect of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans. 1. Growth hormone. Psychoneuroendocrinology 11, 447–461.
18. Lipsey, J. K., Spencer, W. C., Rabins, P. V. & Robinson, R. G. (1986). Phenomenological comparison of poststroke depression and functional depression. American Journal of Psychiatry 143, 527–529.
19. Lishman, W. A. (1988). Organic Psychiatry (2nd edn.). Blackwell: London.
20. Lovinger, R., Holland, J., Kaplan, S., Grummach, M. M., Boryczka, A. T., Shackleford, R., Salmon, J., Reid, I. A. & Ganong, W. F. (1976). Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs. Neuroscience 1, 443–450.
21. Matussek, N., Ackenhail, M., Hippius, H., Muller, F., Schroder, H. Th., Schultes, H. & Wasilewski, B. (1980). EfTect of clonidine on growth hormone release in psychiatric patients. Psychiatric Research 2, 25–36.
22. Meltzer, H. Y., Kolakowska, T., Fang, U. S., Fogg, L., Robertson, A. W., Lewine, R., Strahilevitz, M. & Busch, D. (1984). Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Archives of General Psychiatry 41, 512–519.
23. Raile, S. (1983). The standards of growth hormone assays. In Evaluation of Growth Hormone Secretion (ed. Z. Laron and O. Butenandt), pp. 189–201. Karger: Basel.
24. Robinson, R. G. (1981). A model for the study of stroke using the rat. American Journal of Pathology 104, 103–105.
25. Robinson, R. G. & Coyle, J. T. (1980). The differential effect of right versus left hemispheric cerebral infarction on catecholamines and behaviour in the rat. Brain Research 213, 387–395.
26. Robinson, R. G. & Szetela, B. (1981). Mood changes following left hemisphere injury. Annals of Neurology 9, 447–453.
27. Robinson, R. G., Kubos, K. L., Starr, L. B., Rao, K. & Price, T. R. (1984). Mood changes in stroke patients: importance of location of lesion. Brain 107, 81–93.
28. Ross, E. D., Gordon, W. A., Hibbard, M. & Egelko, S. (1986). The dexamethasone suppression test, poststroke depression and the validity of DSM-111 based diagnostic criteria. American Journal of Psychiatry 143, 1200–1201.
29. Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry 122, 509–522.
30. Shinar, D., Gross, C. R., Price, T. R., Bonko, M., Bolduc, P. L. & Robinson, R. G. (1986). Screening for depression in stroke patients: the reliability and validity of the Center for Epidemiologic Studies Depression Scale. Stroke 17, 241–245.
31. Siever, L. J., Uhde, T. W., Silberman, E. K., Jimerson, D. C., Aloi, J. A., Post, R. M. & Murphy, D. L. (1982). Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Research 6, 171–183.
32. Sinyor, D., Jacques, P., Kaloupek, D. G., Becker, R., Goldberg, M. & Coppersmith, H. (1986). Poststroke depression and lesion location: an attempted replication. Brain 109, 537–546.
33. Starkstein, S. E. & Robinson, R. G. (1989). Affective disorders and cerebral vascular diseases. British Journal of Psychiatry 154, 170–182.
34. Terry, L. C. & Martin, J. B. (1981). Evidence for alpha-adrenergic regulation of episodic growth hormone and prolactin secretion in the undisturbed male rat. Endocrinology 108, 1869–1873.